http://nopr.niscpr.res.in/handle/123456789/61243 Sat, 10 Oct 2026 17:08:17 GMT 2026-10-10T17:08:17Z http://nopr.niscpr.res.in/handle/123456789/61255 Title: Identifying, Preventing and Overcoming Trademark Bullying in Indonesia Authors: Permata, Rika Ratna; Ramli, Tasya Safiranita; Priowirjanto, Enni Soerjati; Utama, Biondy Abstract: On the one side, trademark owners must be proactive in protecting their trademark from other trademarks to prevent their trademark from becoming generic. However, on the other side, it can cause negative effects for the community, especially trademark owners who are categorized as small business owners. The act of trademark owners excessively protecting their trademarks by accusing small businesses of violating their trademark is termed “trademark bullying”. This article's discussion will focus on a number of important goals. In addition, it will provide explanations and definition of trademark bullying, as well as identifying preventing and overcoming trademark bullying in Indonesia. It can be concluded that trademark bullying has occurred in Indonesia. The disputed issue is the use of a common word that the trademark owner considers an essential element of his/her trademark. To prevent trademark bullying that takes issue with the use of the common word of a brand, Indonesian government must start making regulations on descriptive fair use defense in order to provide legal certainty and healthy business competition. To be able to overcome trademark bullying, victims can try shaming the trademark bullies. It is considered quite effective and can make trademark bullies rethink in sending cease-anddesist letter or lawsuit against small business owners. Page(s): 389-396 Sun, 01 Jan 2023 00:00:00 GMT http://nopr.niscpr.res.in/handle/123456789/61255 2023-01-01T00:00:00Z http://nopr.niscpr.res.in/handle/123456789/61253 Title: Impact of Patent (Amendment) Act, 2005 on Indian Pharmaceutical Industry Authors: Singh, Keerti Abstract: Since 1901, the Indian pharmaceutical industries have expanded and strengthened to become a significant supplier of healthcare items, meeting around 90% of the nation’s need for bulk pharmaceuticals, drugs intermediates, chemicals for the medicinal base, pharmaceutical compounds, medicinal formulas, drugs, tablets, orals, respules/capsules, and injectables. Indian pharmaceutical industry has embarked not only on national markets but it has an esteemed and illustrious position in international markets also. India is the world’s third-largest pharmaceutical manufacturer by volume and fourteenth-largest by value. The growth and empowerment of the pharmaceutical industry is totally attributed to the rules and principles governing the operations and evolution of the pharmaceutical industry in India. These rules are the controlling guidelines mandated by the Government of India, through the Acts and amendments made in the acts at various times. One of the major and most influential amendment is the Patent (Amendment) Act, 2005. This act has provided new dimensions and horizons to the Indian pharmaceutical industry and a good number or rational researches have been performed on this subject. It has thus been a fascination to dig the researcher’s points of views about how The Patent (Amendment) Act, 2005 after TRIPS has impacted the Indian pharmaceutical industry since this act has been passed. This survey paper is an attempt to bring out the deviations and modifications, Indian pharmaceutical industry has been gone through, since year 2005 Page(s): 397-414 Sun, 01 Jan 2023 00:00:00 GMT http://nopr.niscpr.res.in/handle/123456789/61253 2023-01-01T00:00:00Z http://nopr.niscpr.res.in/handle/123456789/61251 Title: Intellectual Property Rights in Context of New Education Policy 2020 Authors: Sharma, Arpana; Bhardwaj, Aadyaa; Pruthi, Madhu; Sharma, Monika Abstract: Intellectual property rights (IPRs) are the backbone of innovation and new ideas. They encourage prospective researchers and protect their interests. These rights give innovators an exclusive right over their creations for a certain period. India being a member of the World trade organization has complied with its obligations related to intellectual property rights. In India, IPRs are divided into the following categories as Copyright, patents, designs, and trademarks. The New Education Policy (NEP) 2020 puts major emphasis on ability enhancement and skill development with a technology-driven approach to teaching-learning processes accompanied by creativity and innovation. The purpose of IPR is to provide protection for the results of investments of individuals and stimulate innovation thereby rewarding and encouraging creative work in the development of NEP 2020. In today’s era, it is very important to create IPR awareness within academic institutions among faculty members and students so that they can patent their innovative research work and consequently benefit the stakeholders. IPRs have also gained substantial importance with the advent of information technology. IPR is of prime importance in sustaining the Global business environment and hence subsistence all over the globe. These rights uplift the inquisitive mindset by duly acknowledging and providing benefits to the originator. The absence and inadequate executionof these rights may impede the social, technical, and economic growth of anation. Hence appropriate propagation of IPR knowledge and its implementation is of paramount significance in the context of NEP 2020. Page(s): 415-419 Sun, 01 Jan 2023 00:00:00 GMT http://nopr.niscpr.res.in/handle/123456789/61251 2023-01-01T00:00:00Z http://nopr.niscpr.res.in/handle/123456789/61249 Title: Patent Waiver on Covid Vaccine: Access for all or Global Supply Crisis? Authors: Choudhary, Latika; Daga, Hardik Abstract: The Coronavirus disease 2019 or COVID-19, pandemic has transpired disastrous effects in the world in multiple forms ranging from the high death tolls to the steep fall in global economy. Even so, it had managed to provide a silver lining in the form of unanimity of researchers from several disciplines, who united to contribute blood, sweat and tears to present to the world the miracle of science- vaccines. One can only imagine the extent of investment which has gone into development of the few vaccines we have today. In fact the research continues to be in full swing, with the hope and zest to better. While every country fights the pandemic with vigor, it is the pharmaceutical R&D which is expected of breakthrough discoveries as a solution. Where the pressure to succeed is tremendous, millions invested and no option to fail is it not justified to expect and deserve patent for the same. This paper will dwell into the justification of patent over Covid-19 vaccines, the ongoing debate over patent waiver and analyze whether the waiver will in fact facilitate greater access and affordability of vaccines or prove to be an impediment for global supply. Page(s): 420-426 Sun, 01 Jan 2023 00:00:00 GMT http://nopr.niscpr.res.in/handle/123456789/61249 2023-01-01T00:00:00Z